相关实验视频
Updated: May 24, 2025

03:25
Simple Continuous Glucose Monitoring in Freely Moving Mice
Published on: February 24, 2023
5.1K
使用持续血糖监测进行输血依赖性糖尿病前期的表征:血糖护理研究
Angela Zanfardino1, Gulsum Ozen2, Giorgia Ippolito1
1Regional Center for Pediatric Diabetes, Department of Pediatrics - University of the Study of Campania, via Sant'Andrea delle Dame, 4, Naples 80138, Italy.
Diabetes research and clinical practice
|March 3, 2025
概括
连续葡萄糖监测 (CGM) 可靠地确定了 37% 的输血依赖性沙拉西米亚 (TDT) 患者的糖尿病前期,即使使用正常标准测试. 在TDT中,TAR140 > 6%的指标显示为TDT中失糖症的诊断切线具有前途.
科学领域:
- 内分泌学 在内分泌学.
- 血液学 血液学 血液学
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 输血依赖性沙拉西米亚 (TDT) 患者有患失糖症的风险.
- 持续葡萄糖监测 (CGM) 可以提供对TDT中的葡萄糖代谢的见解.
- 以前的研究表明,CGM可能会高估这种人群中的糖尿病前期.
研究的目的:
- 在TDT患者中使用CGM分析与葡萄糖相关的指标,这些患者的糖尿病查测试呈阴性.
- 为了比较TDT患者和健康对照者之间的CGM衍生的葡萄糖指标.
- 评估TDT患者TAR140>6%的度量和临床/实验室特征之间的关联.
主要方法:
- 在TDT患者和健康对照组中进行了为期7天的CGM评估,这些对照组最初对葡萄糖疾病的查结果为负.
- 分析了葡萄糖指标,包括葡萄糖监测间隔 (GMI) 和时间上限 (TAR).
- 为了进行相关性分析,收集了包括铁过载指数在内的临床和实验室数据.
主要成果:
- 在TDT患者中,HbA1c水平错误地升高,尽管正常的平均葡萄糖和GMI.
- 37%的TDT患者 (7/19) 呈现TAR140>6%,而没有健康对照.
- 在euglycemic (TAR140 ≤ 6%) 和hyperglycemic (TAR140 > 6%) TDT亚组之间发现了GMI,平均葡萄糖和TAR的显著差异. 这些子组之间没有观察到铁过载的差异.
结论:
- 在37%的TDT患者中,CGM可靠地检测出糖尿病前期,这表明患病率高于标准查表明的.
- 在TDT患者中,TAR140 > 6%的指标似乎是诊断TDT患者失糖症的可靠指标.
- CGM为TDT患者的葡萄糖代谢管理提供了有价值的数据,补充了传统的查方法.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Diabetes: Symptoms, Diagnosis, and Complications
495
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
495
Hypoglycemia and Glucagon
149
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
149
Diabetes: Management and Pharmacotherapy
227
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
227
Diabetes Mellitus: Overview and Type I Subtype
2.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.3K
Pathophysiology of Diabetes
842
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
842

